Skip to main content
Clinical Trials/DRKS00007565
DRKS00007565
Completed
未知

Prospective, interventional study on the characterization of circulatoryTumor cells and nucleic acids in patients undergoing aLung carcinoma surgery or pulmonary metastasisctomy(Pilot study)

niversitätsklinikum Freiburg - Klinik für Thoraxchirurgie0 sites29 target enrollmentApril 10, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
C34
Sponsor
niversitätsklinikum Freiburg - Klinik für Thoraxchirurgie
Enrollment
29
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 10, 2015
End Date
June 12, 2017
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Freiburg - Klinik für Thoraxchirurgie

Eligibility Criteria

Inclusion Criteria

  • \- submission of written consent from the patient after informing
  • \- Age \= 18 years
  • Diagnosis of primary lung carcinoma or pulmonary metastases
  • \- indication for surgical resection (atyp. Resection, lobectomy,
  • Pneumonectomy, metastasisctomy)
  • \- In patients who are operated on a malignancy, the
  • Histopathological findings including the adequate examinations
  • be. No additional biopsy, examination or intervention must be within the framework
  • Of the study.
  • \-template the written consent of the patient after informing

Exclusion Criteria

  • \- Diagnosis of a second (synchronous) malignoma, except basal cell carcinoma.
  • \- hemoglobin \<8 g / dl on the morning of operation
  • \- Intraoperative transfusion of more than four erythrocyte concentrates
  • \- Diagnosis of malignancy other than basal cell carcinoma.
  • \- hemoglobin \<8 g / dl on the morning of operation
  • \- Intraoperative transfusion of more than four erythrocyte concentrates. No more
  • Blood collection will be taken during or on the first postoperative day.

Outcomes

Primary Outcomes

Not specified

Similar Trials